Bulletin
Investor Alert

New York Markets Open in:

Century Therapeutics Inc.

NAS: IPSC

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 15, 2021, 5:17 p.m.

/zigman2/quotes/210490648/composite

$

19.31

Change

0.00 0.00%

Volume

Volume 723

Quotes are delayed by 20 min

/zigman2/quotes/210490648/composite

Previous close

$ 19.53

$ 19.31

Change

-0.22 -1.13%

Day low

Day high

$18.90

$19.98

Open

52 week low

52 week high

$16.29

$32.90

Open

Annual Financials for Century Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20192020 5-year trend
Sales/Revenue -----
Cost of Goods Sold (COGS) incl. D&A ---249,0001.4M
COGS excluding D&A -----
Depreciation & Amortization Expense ---249,0001.4M
Depreciation ---249,0001.4M
Amortization of Intangibles -----
Gross Income ---(249,000)(1.4M)
20192020 5-year trend
SG&A Expense ---19.78M47.77M
Research & Development ---14.27M39.68M
Other SG&A ---5.52M8.09M
Other Operating Expense -----
Unusual Expense ---225.95M4.72M
EBIT after Unusual Expense ---(245.98M)(53.9M)
Non Operating Income/Expense ---1.21M704,000
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense ----381,000
Gross Interest Expense ----381,000
Interest Capitalized -----
Pretax Income ---(244.77M)(53.58M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income ---(244.77M)(53.58M)
Minority Interest Expense -----
Net Income ---(244.77M)(53.58M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries ---(244.77M)(53.58M)
Preferred Dividends -----
Net Income Available to Common ---(244.77M)(53.58M)
EPS (Basic) -----
Basic Shares Outstanding -----
EPS (Diluted) -----
Diluted Shares Outstanding -----
EBITDA ---(19.78M)(47.77M)
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.